The target uric acid level in multimorbid patients with gout is difficult to achieve: data from a longitudinal Swiss single-centre cohort

To characterise adherence and treat-to-target (T2T) strategy in gout patients within a Swiss tertiary hospital. Consecutive presenting patients with proven gout were prospectively included in this cohort. Symptoms, comorbidities, medication and laboratory values were assessed (during hospitalisation...

Full description

Saved in:
Bibliographic Details
Published in:Swiss medical weekly 2019-09, Vol.149 (3536), p.w20121-w20121
Main Authors: Ankli, Barbara, Berger, Christoph T, Haeni, Nicolas, Kyburz, Diego, Hügle, Thomas, So, Alexander K-L, Daikeler, Thomas
Format: Article
Language:English
Subjects:
Arthritis
crystal
flare
gout
hyperuricaemia
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To characterise adherence and treat-to-target (T2T) strategy in gout patients within a Swiss tertiary hospital. Consecutive presenting patients with proven gout were prospectively included in this cohort. Symptoms, comorbidities, medication and laboratory values were assessed (during hospitalisation and at planned 3- and 12-month follow-up assessments). 116 patients (98 men) with a mean age of 67 (range 23-94 years) were included, 74% of whom had active arthritis. Comorbidities were frequent: hypertension, renal impairment, and obesity were present in 72, 55 and 35% of patients, respectively. Thirty-five percent of patients received urate-lowering treatment at inclusion. Only 62 and 50% attended the 3- and 12-month follow-up. The target serum uric acid level of
ISSN:1424-3997
1424-3997
DOI:10.4414/smw.2019.20121